Logo

Qatar Center to Use Illumina Genotyping Platform to Study Arabian Gulf Region Founder Populations

May 09, 2006

NEW YORK, May 9 (GenomeWeb News) - Illumina said today that the genetic facility at the Shafallah Center for Children with Special Needs in Doha, Qatar, has installed an Illumina BeadLab genotyping platform.

 

The Shafallah Center will use the BeadLab as part of its research on rare autosomal recessive diseases as well as complex diseases such as diabetes, Illumina said.

 

All disease research at the facility will involve the collection and analysis of clinical, genetic, and family history data. The ShafallahGeneticsMedicalCenterwill have access to samples from founder populations indigenous to the Persian Gulf region, Illumina said.

 

Financial terms were not disclosed.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.